IBDIQ

Enhancing expertise.

Inflammatory bowel disease (IBD) is on the rise, placing greater demands on healthcare professionals (HCPs). With responsibilities shifting and knowledge gaps growing, Takeda saw an opportunity to develop educational content to help HCPs keep up with the pace of change in IBD care.

Pivot helped Takeda reimagine IBD education for HCPs with a bold solution: IBDIQ. As the first-of-its-kind, digital disease state education learning management system (LMS), IBDIQ offers HCPs an opportunity to grow their knowledge across a range of key topics. Created in collaboration with IBD specialists, the content is designed to help more HCPs get the information they need, when they need it, to help more patients with IBD.

  • Naming & visual identity
  • Brand guidelines
  • Brand voice & messaging
  • Website
  • Learning management system
  • Video
  • CRM
  • Social
  • Print

I continue to get compliments on IBDIQ, and the healthcare professionals were blown away by the quality of the videos, the site, etc.

Kate Iwanski
Associate Director, Regional Marketing Lead

©2025 Takeda Pharmaceuticals U.S.A., Inc. All rights reserved. Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited. IBDIQ is a trademark of Takeda Pharmaceuticals U.S.A., Inc.